Patents
Sitemap › C07 - Organic chemistry › C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids › C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
10/2007
10/25/2007US20070248959 Genetic markers for obesity
10/25/2007US20070248956 Methods and Compositions for Autism Risk Assessment
10/25/2007US20070248954 Primers for Use in Detecting Beta-Lactamases
10/25/2007US20070248679 Vaccine
10/25/2007US20070248628 Immunogens in cancer stem cells
10/25/2007US20070248616 Canine Respiratory Coronavirus (Crcv) Spike Protein, Polymerase and Hemagglutinin/Esterase
10/25/2007US20070248614 Vaccination
10/25/2007US20070248613 Human Antibodies Interacting with Hiv Gp41
10/25/2007US20070248606 Treatment of Alzheimer's disease
10/25/2007US20070248604 Inhibits fibroblast growth factor (FGF); used to treat a tumor, a cancer, and/or a cell proliferative disorder
10/25/2007US20070248593 Identifying and characterizing novel human secreted proteins and their genes ; promotes vascularization; screening methods
10/25/2007US20070248588 Novel Compositions and Methods for the Treatment of Immune-Related Diseases
10/25/2007US20070248579 Use of Secreted Protein Products for Preventing and Treating Pancreatic Diseases and/or Obesity and/or Metabolic Syndrome
10/25/2007US20070248578 Mrna Transfected Antigen Presenting Cells
10/25/2007US20070248543 Chicken Deoxycytidine and Deoxyadenosine Kinase Enzymes and Their Use
10/25/2007US20070248539 AgRM2 antigen
10/25/2007US20070248535 Methods to treat or prevent hormone-resistant prostate cancer using siRNA specific for protocadherin-PC, or other inhibitors of protocadherin-PC expression or activity
10/25/2007CA2649325A1 Kits and methods for generating 5' capped rna
10/25/2007CA2649138A1 Rnai-mediated inhibition of spleen tyrosine kinase-related inflammatory conditions
10/25/2007CA2649114A1 Compositions and methods for modulating gene expression
10/25/2007CA2648949A1 Detection of influenza a virus
10/25/2007CA2646253A1 Method for cloning and expression of nrui restriction endonuclease
10/25/2007CA2636424A1 Immunostimulatory combinations of tnfrsf, tlr, nlr, rhr, purinergic receptor, and cytokine receptor agonists for vaccines and tumor immunotherapy
10/24/2007EP1847620A2 Methods of diagnosis of prostate cancer, compositions and methods of screening for modulators of prostate cancer
10/24/2007EP1847605A2 Methods for producing members of specific binding pairs
10/24/2007EP1846579A2 Method for extraction and identification of nucleic acids
10/24/2007EP1846576A2 Biomarkers for tissue status
10/24/2007EP1846449A2 Irta-2 antibodies and their uses
10/24/2007EP1846432A1 Method for making targeted therapeutic agents
10/24/2007EP1846431A1 Purification of oligonucleotides
10/24/2007EP1846032A2 Luca2 and antibodies that bind thereto
10/24/2007EP1846024A2 Mycobacterial mutants affecting host apoptosis
10/24/2007EP1846023A2 A plasmodium vivax hybrid circumsporozoite protein and vaccine
10/24/2007EP1846004A1 New uses of dinucleotide polyphosphate derivatives
10/24/2007EP1730304A4 Salivary mrna profiling, biomarkers, and related methods and kits of parts
10/24/2007EP1709163A4 Methods for degrading lignocellulosic materials
10/24/2007EP1668157A4 Hairpin-labeled probes and methods of use
10/24/2007EP1636333A4 Nucleotide sequences for regulating gene expression in plant trichomes and constructs and methods utilizing same
10/24/2007EP1633892A4 Detection methods for disorders of the lung
10/24/2007EP1628647A4 Novel lipids for transfection of nucleic acids
10/24/2007EP1549772A4 Methods and compositions for detection and analysis of polynucleotides using light harvesting multichromophores
10/24/2007EP1481096A4 Surface modification, linker attachment, and polymerization methods
10/24/2007EP1198591A4 Nanoparticles having oligonucleotides attached thereto and uses therefor
10/24/2007EP1064359B1 Phenol oxidizing enzyme enzymes
10/24/2007EP0723588B1 Activin receptors-like kinase (alk), belonging to the tgf receptor family and/or to the bmp receptor family
10/24/2007CN101061237A Abnormalities of phosphatase 2A(PP2A) for diagnosis and treatment of alzheimer's disease
10/24/2007CN101061236A Methods of detecting gene expression in normal and cancerous cells
10/24/2007CN101060855A Gastrointestinal proliferative factor and uses thereof
10/24/2007CN101058808A Breast cancer relevant p69 gene, coding protein and application thereof
10/24/2007CN101058798A Recombination Lactococcus lactics for expressing pig infectious gastroenteritis virus S protein and preparation method thereof
10/24/2007CN101058595A Ibonucleic acid, and preparation method and application thereof
10/24/2007CN101058590A Extraction method for acute pancreatitis model animal pancreas tissue RNA
10/24/2007CN101057976A Substances for preventing and treating autoimmune diseases
10/24/2007CN100344765C DNA sequences for regulating transcription
10/24/2007CN100344761C Boea clarkeane drought-resistant and salt-tolerance related gene and its coding protein and use
10/24/2007CN100344646C Oligonucleotide-containing pharmacological compositions and their use
10/24/2007CN100344645C Process for purifying oligonucleotide synthons
10/23/2007US7285658 For the treatment of viral infections, microbial infections, and proliferative disorders; contain di- or triphosphate moeity mimetics, such as those containing boron anions
10/23/2007US7285657 Rubisco small subunit promotes from Brassica rapa and uses thereof
10/23/2007US7285656 An isolated polynucleotide sequence of at least 45 nucleotides, and having at least two Dof element which individually may be in forward or inverted orientaion(Dof being separated from each other by 10 to 20 nucleotides)
10/23/2007US7285655 Can be used for identifying mu3 opiate receptor agonists and antagonists
10/23/2007US7285653 A vector for heterologous expression of a gene cluster for spinosyn biosynthesis; can provide data which can be employed within the framework of a genome sequencing project and metabolic engineering, based thereupon, for increasing spinosyn production.
10/23/2007US7285652 Isolated nucleic acid molecule encoding the modified phytochrome A
10/23/2007US7285650 Genetic engineered nucleotide sequences codes a recombinant protein for treating allergy
10/23/2007US7285648 IL-1 delta DNA and polypeptides
10/23/2007US7285644 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2007US7285641 Antibodies against gene products related to Werner's Syndrome
10/23/2007US7285636 Vectors with DNA encoding pro polypeptides
10/23/2007US7285632 Biological insect control agent for use in agriculture
10/23/2007US7285628 PRO1867 polypeptides
10/23/2007US7285627 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocyte/pericyte/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis
10/23/2007US7285623 Novel DNA and to the recombinant production of novel polypeptides encoded by that DNA
10/23/2007US7285541 Antisense treatments for melanoma by inhibition of clusterin, also known as testosterone-repressed prostate message-2, for example by administration of antisense oligonucleotides specific for clusterin
10/23/2007US7285538 Gene therapy; mutant Dna
10/23/2007US7285537 Oligonucleotide therapeutic agent and methods of making same
10/23/2007US7285422 Depositing a defined and controlled 0.2 to 20 nanoliter volume of a solution of 3-hydroxypicolinic acid matrix, an evaporating solvent and no analyte at a plurality of discrete locations on the surface of a substrate by an automated dispenser; evaporating the solvent, forming array of spots on surface
10/23/2007US7285410 Using trangenic microorganism having nitrilase and amidase activities to convert (E,Z)-2-methyl-2-butenenitrile into (E and Z)-2-methyl-2-butenoic acids
10/23/2007US7285409 Isolated gum operon from Xyllela fastidiosa, isolated nucleic acid molecules therefrom, and uses thereof
10/23/2007US7285407 Genes of cell wall-degrading enzymes derived from aspergillus, and method for the production the enzymes
10/23/2007US7285406 Nucleic acid fragments encoding nitrile hydratase and amidase enzymes from Comamonas testosteroni 5-MGAM-4D and recombinant organisms expressing those enzymes useful for the production of amides and acids
10/23/2007US7285405 To prepare jerangolid in pharmaceutically useful quantities; polypeptide, antitumor agents, antibiotics
10/23/2007US7285400 High bone mass gene of 11q13.3
10/23/2007US7285399 Compositions and methods using the yeast YMR107W promoter
10/23/2007US7285398 Transmembrane proteins for use in identifying modulator for treatment of inflammatory, splenic, bone, respiratory and cell proliferative disorders
10/23/2007US7285395 Drug screening; prevention and treatment of fatty heart; genetic engineering and expression
10/23/2007US7285388 Methods for identification of alport syndrome
10/23/2007US7285385 Methods for analyzing animal products
10/23/2007US7285384 Parallel genotyping of multiple patient samples
10/23/2007US7285383 Cell with recombinant nucleic acid comprisinga hepatitis C virus internal ribosome etry site (IRES) operably linked to a polynucleotide encoding a reporter protein; and a test compound; drug screening for viricides; determining if translation is allowed or prevented by interaction with drug or cell
10/23/2007US7285288 P-ethoxy polynucleotide that hybridizes to a Bcl-2-encoding polynucleotide under intracellular conditions and associated with a neutral lipid and its use in the treatment of follicular lymphoma
10/23/2007US7285265 Stable adenoviral vectors and methods for propagation thereof
10/23/2007US7285242 Apparatus for use in the detection of signal form radioactive particles
10/23/2007CA2217780C Polyether nucleic acids
10/18/2007WO2007118249A2 Personal electronic device carrier
10/18/2007WO2007118206A2 Canine influenza virus
10/18/2007WO2007117852A2 Targeted deletions using retroelement-mediated placement of recombination sites
10/18/2007WO2007116129A1 A universal labeling system
10/18/2007WO2005101196A8 Integrated configuration system for use in a process plant
10/18/2007WO2005067391A3 Diagnostic test for parkinson's disease
10/18/2007WO2004058989A3 Target-dependent transcription
1 ... 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 ... 899